Description
Efikas MR 30 mg 90 Tablet Indications
Efikas MR 30 mg; It is effective in all forms of diabetes without nutritional deficiency, maturity diabetes, obesity diabetes, senile diabetes and diabetes associated with vascular complications. It can be used in conjunction with insulin therapy in patients on insulin therapy, but continued medical and biological control is essential in such cases.
Efikas MR 30 mg 90 Tablets Active Ingredient
Gliclazide, which is the active ingredient of Efikas , has a National Library of Medicine registration number (CAS No) of Gliclazide with its original name, and its molecular weight is 323.41054 g/mol, and its formula is C 15 H 21 N 3 O 3 S. The pregnancy / pregnancy category of gliclazide is ?, drugs containing this active substance are taken orally.
Chemical Structure Picture for Gliclazide, the main active ingredient of Efikas drug:
Category of Efikas MR 30 mg 90 Tablets
Digestive System and Metabolism - Diabetes (Diabetes) Drugs - Blood Sugar Lowering Drugs - Sulfonamides - Gliclazide
Efikas MR 30 mg 90 Tablet Warnings
medicine tr warning: Do not use any medicine without consulting your doctor or pharmacist. Do not forget that the information provided on the internet sites about medicines does not replace the prescription that a specialist will give after examining you. On this page, Efikas users or other people cannot comment on the drug.